Adtalem Global Education (NYSE:CVSA) Releases FY 2027 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) updated its FY 2027 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 8.900-9.150 for the period, compared to the consensus estimate of 8.880. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CVSA. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Truist Financial boosted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Barrington Research reissued an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Adtalem Global Education has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Stock Up 13.3%

Shares of NYSE:CVSA opened at $140.84 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The firm has a 50-day moving average price of $124.68. The company has a market cap of $4.79 billion, a P/E ratio of 20.01, a PEG ratio of 0.94 and a beta of 0.62. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 21.05%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, equities analysts anticipate that Adtalem Global Education will post 8.85 EPS for the current year.

Insider Buying and Selling at Adtalem Global Education

In other Adtalem Global Education news, SVP Douglas G. Beck sold 2,439 shares of the firm’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $135.34, for a total transaction of $330,094.26. Following the transaction, the senior vice president owned 33,070 shares of the company’s stock, valued at approximately $4,475,693.80. This trade represents a 6.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,529 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $130.78, for a total transaction of $330,742.62. Following the completion of the sale, the chief executive officer directly owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. This represents a 0.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,694 shares of company stock valued at $2,098,614 in the last quarter. Corporate insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.